By stabilizing glucose levels, semaglutide reduces the energy crashes and cravings that sabotage PCOS management efforts
Promising therapeutics include semaglutide (Ozempic and Wegovy ), an agonist for glucagon-like peptide-1 (GLP-1) receptor, and tirzepatide (Mounjaro ), a dual agonist for GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
In general, reported adverse drug reactions are transient and mild in intensity
Deciding whether Semaglutide is right for treating your PCOS should be made collaboratively with your healthcare provider
Market observers expect that additional information regarding approvals and product availability could emerge as the regulatory review process progresses
and, most importantly, protect the skin from poor texture and thereby lead to healthy and soft skin